Kendall Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$705K Hold
35,015
– – 0.12% 146
2026
Q2
$606K Sell
35,015
-300
-0.8% -$4.11K 0.1% 154
2026
Q1
$439K Buy
35,315
+1,050
+3% +$14.1K 0.09% 168
2025
Q4
$432K Buy
34,265
+8,595
+33% +$98.3K 0.09% 167
2025
Q3
$257K Buy
25,670
+6,565
+34% +$58.9K 0.06% 210
2025
Q2
$155K Buy
+19,105
New +$144K 0.04% 217

Other funds holding AMRX

Kendall Capital Management's AMRX Position: Q3 2026 in Review

Kendall Capital Management held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 35,015 shares worth $705K. The position accounts for 0.12% of the portfolio, ranked #146.

Kendall Capital Management first reported a position in AMRX in Q2 2025 and has held it in 6 quarters since. 273 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Kendall Capital Management held 35,015 shares of Amneal Pharmaceuticals worth $705K as of Q3 2026.
  • Kendall Capital Management left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
  • Amneal Pharmaceuticals made up 0.12% of Kendall Capital Management's portfolio in Q3 2026, its #146 holding.
  • Kendall Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 273 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Kendall Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.